Burning Rock Biotech Files 6-K Report
Ticker: BNR · Form: 6-K · Filed: Dec 4, 2024 · CIK: 1792267
Sentiment: neutral
Topics: sec-filing, 6-k, foreign-private-issuer
TL;DR
Burning Rock Biotech filed a 6-K, standard reporting for foreign issuers.
AI Summary
Burning Rock Biotech Ltd. filed a Form 6-K on December 4, 2024, incorporating by reference certain information from Exhibit 99.1. This filing is for the month of December 2024 and is a report of a foreign private issuer. The company is incorporated in the People's Republic of China and its principal executive offices are located in Guangzhou, Guangdong.
Why It Matters
This filing indicates ongoing reporting requirements for Burning Rock Biotech Ltd. as a foreign private issuer, providing updates to the SEC.
Risk Assessment
Risk Level: low — This is a routine SEC filing for a foreign private issuer and does not contain specific financial or operational news that would immediately impact risk.
Key Players & Entities
- Burning Rock Biotech Ltd (company) — Registrant
- 001-39316 (company) — SEC File Number
- 20241204 (date) — Filing Date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide certain information that the issuer makes public in its home country or distributes to its security holders.
What is the filing date of this Form 6-K?
This Form 6-K was filed on December 4, 2024.
What is the company's principal executive office address?
The company's principal executive offices are located at No.5 Xingdao Ring Road North, International Bio Island, Guangzhou, Guangdong, People's Republic of China.
What is the SEC file number for Burning Rock Biotech Ltd?
The SEC file number for Burning Rock Biotech Ltd. is 001-39316.
What information is being incorporated by reference?
Exhibit 99.1 of this current report on Form 6-K is being incorporated by reference, excluding specific paragraphs and tables related to Non-GAAP Measures.
Filing Stats: 219 words · 1 min read · ~1 pages · Grade level 13.5 · Accepted 2024-12-04 06:06:25
Filing Documents
- d891460d6k.htm (6-K) — 10KB
- d891460dex991.htm (EX-99.1) — 214KB
- 0001193125-24-270284.txt ( ) — 225KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Burning Rock Biotech Limited By: /s/ Yusheng Han Name: Yusheng Han Title: Chief Executive Officer Date: December 4, 2024 4